TSX-V:ATE$0.65>

Welcome

Anti-inflammatory painkillers are prescribed hundreds of millions of times every year, yet they all are associated with serious and potentially life-threatening ulcers and intestinal bleeding. These are major, long-standing medical problems.

Antibe's portfolio of patented drugs includes versions of existing anti-inflammatory drugs modified with the goal of improving safety. Our lead drug, ATB-346, targets the global need for a safe anti-inflammatory painkiller.

Read More...
Designed and Powered by ADNET